VAERS reports by lot

GSK Varicella/Shingles lot P2J7E: VAERS reports

25 VAERS reports list lot P2J7E as a GSK Varicella/Shingles vaccine, received between 2021-03-09 and 2022-01-02. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
4%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2026%
General / Systemic (non-local)1215%
Dermatological (non-injection-site)1114%
Neurological912%
Allergic / Anaphylactic79%
Cardiac / Cardiovascular68%
Gastrointestinal56%
Musculoskeletal45%
Thrombotic / Hematological23%
Respiratory23%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania4
New Jersey4
Florida2
Texas2
California2
Arizona1
Maryland1
Illinois1
Ohio1
Kentucky1
Michigan1
New Hampshire1

Reports by month received

2021-034
2021-045
2021-057
2021-062
2021-072
2021-091
2021-102
2021-121
2022-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.